| Comparison of Combined Intravitreal Bevacizumab and Oral Acetazolamide Versus Intravitreal Bevacizumab Alone for the Treatment of Macular Edema Secondary to Retinal Vein Occlusions (NCT05290948) | Shahid Beheshti University of Medical Sciences | 2022-03-12 |
| Changes After Suprachoroidal Injection. (NCT05288192) | Benha University | 2022-02-15 |
| Macular Thickness and Visual Acuity in Diabetic Hypertensive Patients (NCT05209971) | Sohag University | 2022-01-01 |
| High Resolution Optical Coherence Tomography (NCT05130385) | Insel Gruppe AG, University Hospital Bern | 2021-11-30 |
| Fundus Image-guided Focal Electroretinography, Usability Study (NCT05100511) | Maculaser Oy | 2021-11-04 |
| Effectiveness of Periocular Drug Injection in CATaract Surgery (NCT05158699) | Luigi Rondas | 2021-10-13 |
| A Study to Evaluate an Updated Dexamethasone Intravitreal (Into the Eye) Applicator in Adult Participants With Macular Edema Due to Diseases of the Retina (NCT04976777) | AbbVie | 2021-10-12 |
| Efficacy and Safety of Intravitreal Injection of Bevacizumab with and Without Oral Curcumin (NCT06595355) | Isfahan University of Medical Sciences | 2021-10-10 |
| Functional and Anatomical Outcomes of Dexamethasone Intra-vitreal Implant in Patients with Resistant Macular Edema Secondary to Retinal Vein Occlusion After Intravitreal Anti-VEGF Injection (NCT05003258) | Assiut University | 2021-10-07 |
| Comparing Post-intravitreal Injection Pain Scores Using Loteprednol, Bromfenac Sodium, and Artificial Tears Over a 24-hour Period (NCT07090044) | Retina Research Institute, LLC | 2021-08-20 |
| Impact of the Navilas ® Micropulse Laser Treatment for Macular Edema Within the CHU Brugmann Hospital Macular Edema (NCT04857099) | Brugmann University Hospital | 2021-03-09 |
| A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion (NCT04740931) | Hoffmann-La Roche | 2021-03-02 |
| BEOVU Versus Eylea in the Treatment of Diabetic Macular Edema (NCT04955171) | Benha University | 2021-01-12 |
| Smart-TV Application for the Self Examination of the Distance Visual Acuity in Macular Edema Patients (NCT04739137) | Democritus University of Thrace | 2021-01-01 |
| A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema Patients (NCT04635800) | Novartis Pharmaceuticals | 2020-12-10 |
| Effects of Adding Triamcinolone Acetonide to Conbercept Treatment for Refractory Diabetic Macular Edema (CONTE) (NCT04627402) | Zhongshan Ophthalmic Center, Sun Yat-sen University | 2020-11-12 |
| Evaluation of the Retinal Health Monitoring System Thickness Module (NCT04499703) | Kubota Vision Inc. | 2020-11-11 |
| Diabetic Macular Edema (DME) Treatment With Ranibizumab and Dexamethasone or Ranibizumab Only. (NCT04601675) | He Eye Hospital | 2020-10-31 |
| A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO) (NCT04592419) | Kodiak Sciences Inc | 2020-09-25 |
| MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema (NCT04187443) | Shenzhen MingSight Relin Pharmaceuticals Co., Ltd. | 2020-06-02 |
| Bimodal and Coaxial High Resolution Ophtalmic Imaging (NCT04620876) | Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts | 2019-10-01 |
| Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole (NCT04120311) | Targeted Therapy Technologies, LLC | 2019-09-01 |
| The Use of Suprachoroidal Triamcinolone Acetonide to Treat Macular Edema in Retinal Vein Occlusion (NCT05038072) | Damascus University | 2019-07-25 |
| Evaluation of OZURDEX® in Patients With Macular Edema Secondary to Retinal Vein Occlusion in China (NCT03908307) | Allergan | 2019-07-25 |
| High Resolution, High-speed Multimodal Ophthalmic Imaging (NCT04129021) | Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts | 2019-07-03 |
| Long Term Safety of Cooling Anesthesia for Intravitreal Injection (NCT03956797) | Recens Medical, Inc. | 2019-04-15 |
| Targeted Laser in Diabetic Macular Edema (NCT03751501) | Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts | 2019-02-12 |
| Macular Edema Nepafenac vs. Difluprednate Uveitis Trial (NCT01939691) | University of California, San Francisco | 2018-09-12 |
| PPV With Internal Limiting Membrane Peeling for Treatment-Naïve DME (NCT03660345) | Rush Eye Associates | 2018-09-04 |
| ILM Peeling in PDR Patients Undergoing PPV for VH (NCT03660371) | Rush Eye Associates | 2018-09-04 |
| Effect of Vitrectomy on the Evolution of Refractory Diabetic Macular Edema (NCT03603990) | Fondation Ophtalmologique Adolphe de Rothschild | 2018-09-01 |
| Navigated Laser In Branch Retinal Vein Occlusion Study (NCT03651011) | Odense University Hospital | 2018-08-10 |
| A Study to Evaluate THR-317 and Ranibizumab Combination Treatment for Diabetic Macular Oedema (DME) (NCT03499223) | Oxurion | 2018-04-20 |
| Suprachoroidal Injection of Triamcinolone Acetonide With IVT Anti-VEGF in Subjects With Macular Edema Following RVO (NCT03203447) | Clearside Biomedical, Inc. | 2018-03-05 |
| High Resolution Retina Imaging (NCT04128150) | Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts | 2018-01-17 |
| A Study to Evaluate the Effectiveness of Intravitreal Aflibercept in Patients With Diabetic Macular Edema and/or Macular Edema Secondary to Retinal Vein Occlusion, Which Either Have or Have Not Been Pretreated for Their Disease (NCT03161912) | Bayer | 2017-11-24 |
| Risk Factors for the Recurrent Postoperative Macular Edema Treated With OZURDEX (NCT05372562) | Peking University | 2017-07-01 |
| Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial (NCT02623426) | JHSPH Center for Clinical Trials | 2017-03-09 |
| Cytokine and Visual Outcome Variations in Eyes Receiving Aflibercept (NCT03056079) | Unity Health Toronto | 2017-02-28 |
| Cytokine and Visual Outcome Variations in Eyes Receiving Ranibizumab (NCT03056092) | Unity Health Toronto | 2017-02-28 |
| Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO (NCT02980874) | Clearside Biomedical, Inc. | 2017-01-31 |
| A Study to Evaluate the Safety and Efficacy of THR-317 for the Treatment of Diabetic Macular Oedema (DME) (NCT03071068) | ThromboGenics | 2016-12-22 |
| Efficacy and Safety of Three Different Aflibercept Regimens in Subjects With Diabetic Macular Edema (DME) (NCT02818998) | Bayer | 2016-11-16 |
| Retrospective Study of the Safety and Efficacy of Patients With RVO in Subjects Who Completed Parent Study CLS1003-201 (NCT02956330) | Clearside Biomedical, Inc. | 2016-11-01 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Intravitreal LKA651 in Patients With Macular Edema (NCT02867735) | Novartis Pharmaceuticals | 2016-09-21 |
| Analyzing Retinal Microanatomy in ROP (NCT02887157) | Duke University | 2016-07-22 |
| A Study to Assess the Effectiveness of Aflibercept in Routine Clinical Practice in Patients With Diabetic Macular Oedema (NCT02850263) | Bayer | 2016-07-05 |
| Conbercept Ophthalmic Injection for Patients of Central Retinal Vein Occlusion (NCT03223714) | Chengdu Kanghong Biotech Co., Ltd. | 2016-05-24 |
| Safety and Effect on Central Retinal Thickness of BI 1026706 in Patients With Diabetic Macular Edema (NCT02732951) | Boehringer Ingelheim | 2016-04-14 |
| Conbercept Ophthalmic Injection for Patients With Macular Edema Caused by Branch Retinal Vein Occlusion (NCT03108352) | Chengdu Kanghong Biotech Co., Ltd. | 2016-04-13 |
| A Study in Patients With Neovascular Age Related Macular Degeneration or Macular Edema Secondary To Retinal Vein Occlusion to Evaluate Usability of the Ranibizumab (Lucentis®) Prefilled Syringe (PFS) (NCT02698566) | Genentech, Inc. | 2016-03-21 |
| Epiretinal Membrane and Pseudophakic Cystoid Macular Edema (NCT02693353) | Loma Linda University | 2016-02-01 |
| Intravitreal Dexamethasone Implant for Persistent Macular Thickening and Edema After Vitrectomy for Epiretinal Membrane (NCT02995746) | Wills Eye | 2016-01-28 |
| Micropulsed Laser in Association With Anti-VEGF for the Treatment of Macular Edema in Diabetic Patients (LAMED). (NCT02650050) | Fondation Ophtalmologique Adolphe de Rothschild | 2016-01-19 |
| A Safety and Efficacy Study of Dexamethasone Versus Laser Photocoagulation in Participants With Diabetic Macular Edema (NCT02121262) | Allergan | 2016-01-08 |
| Ranibizumab Plus Indomethacin (NCT03261635) | Università degli Studi di Brescia | 2016-01-07 |
| Treatment of CNV With Aflibercept Combined With Pranoprofen Eye Drops or Nutraceutical Support With Omega-3 (NCT03355638) | Università degli Studi di Brescia | 2016-01-01 |
| Investigation of the Change of Vision-related Quality of Life in Subjects Treated With Aflibercept According to EU Label for DME. (NCT02581995) | Bayer | 2015-11-19 |
| Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or Bevacizumab (NCT02559180) | Rishi Singh | 2015-10-01 |
| Simultaneous Therapy With Intravitreal Dexamethasone Implant and Bevacizumab for the Treatment of Macular Edema (NCT02623673) | Retina Clinic, Sao Paulo, Brazil | 2015-09-01 |
| Open-label, Multli-center, Phase 1b/2a Clinical Trial Designed to Evaluate the Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Patients With Macular Edema (NCT02485249) | Eyegate Pharmaceuticals, Inc. | 2015-07-01 |
| PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial (NCT02374060) | JHSPH Center for Clinical Trials | 2015-06-16 |
| Intravitreal Aflibercept Injection for Symptomatic Macular Edema From Retinal Artery Macroaneurysms (NCT02403128) | Kamal Kishore, MD | 2015-05-14 |
| Study to Evaluate Home Vision Testing in Participants Who Receive Ranibizumab (Lucentis®) (NCT02420132) | Hoffmann-La Roche | 2015-04-20 |
| Effect of Dexamethasone Implant in Hard Exudate Complicated With Diabetic Macular Edema (NCT02399657) | Inje University | 2015-02-01 |
| Special Drug Use Investigation of EYLEA for Diabetic Macular Edema (NCT02425501) | Bayer | 2015-01-20 |
| Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO (NCT02303184) | Clearside Biomedical, Inc. | 2015-01-01 |
| Spectral-domain Optical Coherence Tomography of the Eye (NCT02614625) | Augenabteilung Allgemeines Krankenhaus Linz | 2014-12-01 |
| Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis (NCT02255032) | Clearside Biomedical, Inc. | 2014-10-01 |
| A Study of Abicipar Pegol in Patients With Diabetic Macular Edema (NCT02186119) | Allergan | 2014-07-01 |
| An Observational Study of OZURDEX® in Diabetic Macular Edema (DME) (NCT02188173) | Allergan | 2014-07-01 |
| Retrospective Data Collection Study in Patients With Macular Oedema Receiving OZURDEX® (NCT02181530) | Allergan | 2014-07-01 |
| Efficacy and Safety of Lucentis® Use in Patients With Diabetic Macular Edema Evaluating a Spaced Out Follow-up After Intensive Treatment Phase (NCT02032173) | Novartis Pharmaceuticals | 2014-05-19 |
| Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma (NCT01471054) | Arman Mashayekhi | 2014-04-01 |
| Contrast Sensitivity and Diabetic Macular Edema (NCT02217306) | Hospital Juarez de Mexico | 2014-01-01 |
| Development of Intravitreal Ranibizumab by Determining the Pathogenesis of Macular Edema With Retinal Vein Occlusion (NCT02169648) | Tokyo Medical University | 2013-12-01 |
| Longterm Efficiency and Safety of Intravitreal Injections With Bevacizumab in Patients With Neovascularisation or Macular Edema (NCT03211741) | University Hospital, Ghent | 2013-11-22 |
| An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases. (NCT01908816) | Novartis Pharmaceuticals | 2013-09-26 |
| Ozurdex Implant for Macular Edema After Treatment Failure With Anti-VEGF (NCT01946399) | Retina Research Institute, LLC | 2013-09-01 |
| A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular Edema (NCT01918371) | Allergan | 2013-08-02 |
| TAHOE: Intravitreal Dexamethasone Implant (Ozurdex) for Uveitic Macular Edema (NCT01870440) | Northern California Retina Vitreous Associates | 2013-05-01 |
| Ocular Manifestations in Rheumatic Diseases (NCT03753893) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2013-05-01 |
| Ozurdex Versus Ranibizumab Versus Combination for Central Retinal Vein Occlusion (NCT01827722) | Valley Retina Institute | 2013-05-01 |
| Study of Squalamine Lactate for the Treatment of Macular Edema Related to Retinal Vein Occlusion (NCT02614937) | Ohr Pharmaceutical Inc. | 2013-04-01 |
| Evaluation of Changes in Visual Acuity in Patients With Diabetic Macular Edema (DME) Starting Treatment With an Approved Anti-VEGF Therapy (NCT01771081) | Bayer | 2013-04-01 |
| Efficacy and Safety of VEGF Trap Eye in Diabetic Macular Edema (DME) With Central Involvement (NCT01783886) | Bayer | 2013-02-01 |
| Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients With Fair Vision (NCT01795209) | Seoul National University Bundang Hospital | 2013-01-01 |
| A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus (NCT01673191) | Retinal Consultants of Arizona | 2012-11-01 |
| Intravitreal Aflibercept Injection for Radiation Retinopathy (NCT01579760) | Washington University School of Medicine | 2012-11-01 |
| Preoperative Topic Diclofenac as a Prevention of Postoperative Macular Edema in Patients With Diabetic Retinopathy (NCT01694212) | Eye Clinic Medic Zuljan Jukic | 2012-10-01 |
| A Pilot Study of the Effectiveness of Intra-operative Ozurdex® in Vitrectomy Surgery for Epiretinal Membranes (NCT01701518) | Sunnybrook Health Sciences Centre | 2012-10-01 |
| Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO (NCT01692938) | Optos, PLC | 2012-10-01 |
| Safety and Efficacy Study of Dexamethasone in the Treatment of Patients With Macular Edema Following Retinal Vein Occlusion (RVO) (NCT01660802) | Allergan | 2012-09-04 |
| A Retrospective Chart Review of OZURDEX® in Patients With Macular Edema (NCT01805323) | Allergan | 2012-09-01 |
| A Safety and Efficacy Study to Assess OZURDEX® in Patients With Macular Oedema Secondary to Retinal Vein Occlusion (RVO) (NCT01571557) | Allergan | 2012-04-30 |
| Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema (NCT01492400) | Allergan | 2012-03-09 |
| A Long-Term Safety Study of OZURDEX® in Clinical Practice (NCT01539577) | Allergan | 2012-03-01 |
| Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion (NCT01535261) | Novartis Pharmaceuticals | 2012-02-01 |
| Japanese Safety Study of VEGF Trap-Eye in DME (Diabetic Macular Edema) (NCT01512966) | Bayer | 2012-01-01 |
| Study of Ozurdex® Treatment Practice in Patients With Macular Oedema Due to Retinal Vein Occlusion (NCT01618266) | Allergan | 2011-11-01 |